Literature DB >> 5956023

Iron chelation in haematomas at fracture sites.

M C O'Shaughnessy, G M Brunström, J Fielding.   

Abstract

Previous work suggested that during the catabolism of haemoglobin a physico-chemical form of iron was released which was more readily chelatable by desferrioxamine than normal storage forms, as ferritin-haemosiderin. Desferrioxamine chelation was therefore investigated in five patients with major fractures in which haemoglobin catabolism is greatly enhanced by the red cell destruction which proceeds in the associated haematoma. Considerable increases in the amounts of iron mobilized by desferrioxamine were observed from the second day after injury. In severe interstitial haemorrhage, these values tended to increase until 10 to 20 days, and sometimes were as high as chelation values seen in haemochromatosis. These results are considered to support the hypothesis that a highly chelatable form of iron is found at some stage during haemoglobin catabolism.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5956023      PMCID: PMC473285          DOI: 10.1136/jcp.19.4.364

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  THE EFFECT OF DESFERRIOXAMINE ON IRON METABOLISM IN MAN.

Authors:  L HALLBERG; L HEDENBERG
Journal:  Scand J Haematol       Date:  1965

2.  Serum iron determination.

Authors:  D KOK; F WILD
Journal:  J Clin Pathol       Date:  1960-05       Impact factor: 3.411

3.  Iron metabolism in fractures.

Authors:  G NYLANDER
Journal:  Acta Endocrinol (Copenh)       Date:  1955-10

4.  The determination of the total iron-binding capacity of serum.

Authors:  W N RAMSAY
Journal:  Clin Chim Acta       Date:  1957-06       Impact factor: 3.786

5.  Serum iron and operative stress.

Authors:  U FELDTHUSEN; V LARSEN; N A LASSEN
Journal:  Acta Med Scand       Date:  1953

6.  Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.

Authors:  J Fielding; M C O'Shaughnessy; G M Brunström
Journal:  J Clin Pathol       Date:  1966-03       Impact factor: 3.411

7.  DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.

Authors:  J FIELDING
Journal:  J Clin Pathol       Date:  1965-01       Impact factor: 3.411

8.  ESTIMATION OF FERRIOXAMINE AND DESFERRIOXAMINE IN URINE.

Authors:  J FIELDING; M BRUNSTROEM
Journal:  J Clin Pathol       Date:  1964-07       Impact factor: 3.411

  8 in total
  4 in total

1.  Storage iron and desferrioxamine.

Authors:  J Fielding
Journal:  Proc R Soc Med       Date:  1970-12

2.  Siderosis, haemolysis or hepatonecrosis in increasing post-desferrioxamine sideruria in acute viral hepatitis?

Authors:  L A Scuro; G Dobrilla
Journal:  Postgrad Med J       Date:  1967-11       Impact factor: 2.401

3.  Differential ferrioxamine test in haemochromatosis and liver diseases.

Authors:  M Barry; G Cartei; S Sherlock
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

4.  Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores.

Authors:  L W Powell; M J Thomas
Journal:  J Clin Pathol       Date:  1967-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.